| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.0063 | 0.9 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.9 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.0072 | 0.9 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | 0.016 | 0.9 |
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | 0.0083 | 0.9 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | -0.0079 | 0.9 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | 0.0059 | 0.9 |